Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Advanced Follicular Lymphoma Evaluating the Benefit of Maintenance Therapy With Rituximab (MabThera®) After Induction of Response With Chemotherapy Plus Rituximab in Comparison With no Maintenance Therapy

NCT00140582 is registered in ClinicalTrials.gov with Lymphoma Study Association as lead sponsor.

NCT NCT00140582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00140582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Advanced Follicular Lymphoma Evaluating the Benefit of Maintenance Therapy With Rituximab (MabThera®) After Induction of Response With Chemotherapy Plus Rituximab in Comparison With no Maintenance Therapy
Lead sponsor
Lymphoma Study Association
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2004
Completion date
December 31, 2016
Enrollment
1,217 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

follicular lymphoma